Research programme: infectious diseases vaccines - MedImmune/University System of Baltimore
Latest Information Update: 09 May 2014
At a glance
- Originator MedImmune; University System of Maryland
- Class Biological peptides; Immunoconjugates
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Infections